Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
Assess whether chronic administration of gonadotropin-releasing hormone analogues is safe and
effective for the prevention of cyclic attacks of acute porphyria in women.